Recent Posts

The Crackdown on Compounded GLP-1 Meds Has Begun

The end of the tirzepatide shortage has created a fraught moment for many patients taking the compounded version of the drug. As WIRED recently reported, many of these patients are concerned that they will not be able to afford or access the name-brand versions of their medication. While Eli Lilly …

Read More »